The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant chemotherapy in American and Italian patients with BRCA1/2-associated breast cancer.
A. Cappetta
No relevant relationships to disclose
R. Nanda
No relevant relationships to disclose
C. Liao
No relevant relationships to disclose
D. Huo
No relevant relationships to disclose
L. F. Chen
No relevant relationships to disclose
G. Artioli
No relevant relationships to disclose
V. Zagonel
No relevant relationships to disclose
O. I. Olopade
No relevant relationships to disclose